NEW YORK (AP) — Eli Lilly’s drug Cyramza has been approved as a treatment for lung cancer, regulators said Friday.
The Food and Drug Administration is allowing Lilly to market the drug as a treatment for cases that have spread. Earlier this year the FDA approved the drug as a treatment for gastric cancer.
Cyramza fights the formation of blood vessels that feed tumors, and Eli Lilly is also studying the drug as a treatment for colorectal cancer.
The company did not disclose third-quarter sales of Cyramza.
Shares of Eli Lilly and Co. lost $1.53, or 2.1 percent, to $70.08 in afternoon trading as broad market indicators sagged. The Indianapolis company’s stock has surged 40 percent in 2014 and it reached a 10-year high of $75.10 on Thursday.
